Journal profile · PHARMACOLOGY & PHARMACY
JOURNAL OF CLINICAL PHARMACOLOGY
ISSN 1552-4604 · Wiley-Blackwell · UNITED STATES
JOURNAL OF CLINICAL PHARMACOLOGY: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.19; hybrid open access; APC about USD 4,150; median 83 days to acceptance (96 articles, last 24 months); acceptance rate 17% (journal website); 180 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JOURNAL OF CLINICAL PHARMACOLOGY is published by Wiley-Blackwell and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical studies and practices, Pharmacogenetics and Drug Metabolism and Antibiotics Pharmacokinetics and Efficacy, together about 31.1% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Clinical Pharmacology (JCP) is a Human Pharmacology journal designed to provide physicians, pharmacists, research scientists, regulatory scientists, drug developers and academic colleagues a forum to present research in all aspects of Clinical Pharmacology. This includes original research in pharmacokinetics, pharmacogenetics/pharmacogenomics, pharmacometrics, physiologic based pharmacokinetic modeling, drug interactions, therapeutic drug monitoring, regulatory sciences (including unique methods of data analysis), special population studies, drug development, pharmacovigilance, womens’ health, pediatric pharmacology, and pharmacodynamics. Additionally, JCP publishes review articles, commentaries and educational manuscripts. The Journal also serves as an instrument to disseminate Public Policy statements from the American College of Clinical Pharmacology. The journal is a member of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE). Keywords The Journal of Clinical Pharmacology; Journal of Clinical Pharmacology; Clinical Pharmacology; Pharmacology; Pharmacy; Pharmacokinetics; Pharmacogenetics; Pharmacometrics; Pharmaceutical and Medicinal Chemistry; Clinical and Experimental Medical Research; Drug Discovery and Development; Toxicology; American College of Clinical Pharmacology Abstracting and Indexing Information Abstracts in Anthropology (Sage) Abstracts on Hygiene & Communicable Diseases (CABI) Academic OneFile (GALE Cengage) Academic Search Alumni Edition (EBSCO Publishing) Academic Search Complete (EBSCO Publishing) Academic Search Elite (EBSCO Publishing) Academic Search Premier (EBSCO Publishing) Biological Abstracts (Clarivate Analytics) Biological Sciences (ProQuest) BIOSIS Previews (Clarivate Analytics) Biotechnology & Bioengineering Abstracts (ProQuest) Botanical Pesticides (CABI) Business Source Corporate (EBSCO Publishing) CAB Abstracts® (CABI) Calcium & Calcified Tissue Abstracts (ProQuest) CAS: Chemical Abstracts Service (ACS) Chemoreception Abstracts (ProQuest) Chimica Database (Elsevier) CINAHL: Cumulative Index to Nursing & Allied Health Literature (EBSCO Publishing) CSA Neurosciences Abstracts (ProQuest) Dairy Science Abstracts (CABI) Embase (Elsevier) Environmental Impact (CABI) Environmental Science Database (CABI) Environmental Sciences & Pollution Management (ProQuest) Expanded Academic ASAP (GALE Cengage) Forest Science Database (CABI) General OneFile (GALE Ceng
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief John N. van denPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical studies and practicesMedicine11.8%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics10.8%
- Antibiotics Pharmacokinetics and EfficacyMedicine8.5%
- Pharmacological Effects and Toxicity StudiesMedicine6.5%
- Drug Transport and Resistance MechanismsMedicine5.5%
- Pharmacology and Obesity TreatmentMedicine4.5%
- Analytical Methods in PharmaceuticalsChemistry4.1%
- Cardiac electrophysiology and arrhythmiasMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCASCAB AbstractsCINAHLPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.19LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher)
- 4.7Publisher website ·
- CiteScore (publisher) 2025
- 4.7Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 0.92LetPub ·
- h-index
- 104LetPub ·
- h-index
- 155OpenAlex ·
- i10-index
- 5,274OpenAlex ·
- 2-year mean citedness
- 2.01OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 32.1%LetPub ·
Volume
- Articles per year
- 138LetPub ·
- Articles per year (publisher) 2025
- 154Publisher website ·
- Downloads per year (publisher) 2025
- 732,822Publisher website ·
Articles by year OpenAlex count · 10,187 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 164 | 118 | 34 |
| 2025 | 180 | 122 | 288 |
| 2024 | 185 | 107 | 739 |
| 2023 | 212 | 133 | 1,180 |
| 2022 | 189 | 64 | 1,559 |
| 2021 | 227 | 109 | 2,812 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
83 daysMedian, submission to acceptance · P25–P75 58 days – 123 days
- Acceptance to online
- median 20 days (95 articles)
- Submission to online
- median 106 days
- Sample
- 96 articles with submission and acceptance dates (361 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 17%Publisher website ·
- Acceptance rate (publisher) 2025
- 17%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to first decision 2025
- 3 daysPublisher website ·
- Submission to acceptance 2025
- 81 daysPublisher website ·
- Acceptance to publication 2025
- 22 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,780 | — | — | |
| Publisher website | No APC | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 6,500 words
- Reference style
- AMA
- Cover letter
- Required
- Not considered
- Animal research; in vitro research
Article types accepted16, with length limits
- announcementsAnnouncements JCP will publish official notices of interest to the members of the American College of Clinical Pharmacology.Length not stated
- commentariesCommentaries These are invited or unsolicited to give a scientific opinion on a topic pertinent to clinical pharmacology or to comment on an article that will a…Length not stated
- commentaryOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…main text ≤ 1,500 words · references ≤ 15
- editorialJCP is a publication dedicated to clinical (human) pharmacology. Manuscripts are invited that deal with the effects of drugs in humans. Animal research and in v…Length not stated
- letterOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…Length not stated
- letters to the editorOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…main text ≤ 500 words
- meta-analysesMeta-analyses reports should follow the guidelines above for Full Original Research Articles.Length not stated
- meta-analysisOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…Length not stated
- narrative reviewOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…Length not stated
- opinionOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…Length not stated
- original articleOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…main text ≤ 6,500 words · references ≤ 150
- original articlesOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required.Length not stated
- original research articleOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…Length not stated
- reviewOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…main text ≤ 7,000 words · references ≤ 200
- supplementsSupplement issues are published yearly. Submissions must undergo peer review, and final approval rests with the Editor.Length not stated
- systematic reviewOriginal Articles Up to 6500 words, 8 tables/figures total, and up to 150 references. An unstructured abstract is required. Reviews Both narrative and systemati…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Peer review, Plagiarism, Preprints
- AI use Artificial Intelligence Generated Content
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), no…
Source ↗Publisher website ·- Authorship Authorship
The ICMJE recommends that authorship be based on the following 4 criteria: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Drafting the work or revising it critically for important intellectual content; AND Final approval of the version to be published; AND Agreement to be accountable for all aspects of th…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
Refer & Transfer program: if not accepted, may receive recommendation to transfer manuscript to another suitable Wiley journal. Model summary
All authors must disclose any competing or conflicts of interest in a COI statement. In revision, authors are also asked to submit ICMJE COI forms. The information listed on those forms should match the COI statement which will be published at the end of the manuscript. If there are no conflicts of interest to disclose, the statement should read: The authors declare no conflicts of interest.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
Data sharing expected; authors should include a data availability statement. Model summary
This journal expects data sharing and authors should include a statement on this. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- Publication ethics
Ethical responsibilities of authors: committed to upholding integrity of scientific record; authors should refrain from misrepresenting research results. Model summary
The Journal of Clinical Pharmacology is committed to upholding the integrity of the scientific record. Authors should refrain from misrepresenting research results which could damage the trust in the Journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavor.
Source ↗Publisher website ·- License & copyright Copyright & Licensing
Permissions: copyrighted tables/illustrations require written permission from copyright owner and original author. Model summary
You may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons (CC) License. Standard re-use and licensing rights vary by journal. Note that certain funders mandate a particular type of CC license be used. This journal uses the CC-BY, CC-BY-NC and CC-BY-NC-ND Creative Commons Licenses. Self-Archiving Definitions and Pol…
Source ↗Publisher website ·- Peer review Review Process
Initial Review If a manuscript is selected for peer review, it will be sent to at least 2 reviewers. A decision will then be sent to the author, generally within 4 weeks. The JCP review process is single blinded, meaning reviewers know the identity of the authors but authors do not know who the reviewers are. The Editor will recuse himself from all proceedings involving manuscripts in which there …
Source ↗Publisher website ·- Plagiarism Plagiarism Screen
Plagiarism screening: all manuscripts screened by Crossref Similarity Check powered by iThenticate. Model summary
All manuscripts submitted are screened by Crossref Similarity Check powered by iThenticate service, which is a web-crawling software that can compare the current manuscript with multiple published sources.
Source ↗Publisher website ·- Preprints Preprint Policy
The Journal of Clinical Pharmacology will consider for review articles previously available as preprints, on a case-by-case basis, where the author has retained copyright of their work. We ask that you disclose this fact upon submission. You may also post the submitted version of a manuscript to a preprint server at any time. If your manuscript is accepted, you must update any pre-publication vers…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1552-4604
- Print ISSN
- 0091-2700
- Latest issue on the website
- Volume 66, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about JOURNAL OF CLINICAL PHARMACOLOGY
What CAS zone is JOURNAL OF CLINICAL PHARMACOLOGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, JOURNAL OF CLINICAL PHARMACOLOGY is in Zone 4 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JOURNAL OF CLINICAL PHARMACOLOGY?
The latest impact factor listed by LetPub is 2.19; CiteScore 4.7, h-index 155.
How long does peer review take at JOURNAL OF CLINICAL PHARMACOLOGY?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 58–123 days); the journal's website gives an acceptance rate of 17% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JOURNAL OF CLINICAL PHARMACOLOGY?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 4; Manuscript length: ≤ 6,500 words; Reference style: AMA; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index JOURNAL OF CLINICAL PHARMACOLOGY?
According to LetPub and DOAJ records, JOURNAL OF CLINICAL PHARMACOLOGY is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAS, CAB Abstracts and CINAHL; that list has not been checked against each database.
Is JOURNAL OF CLINICAL PHARMACOLOGY open access, and what is the APC?
JOURNAL OF CLINICAL PHARMACOLOGY is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .